Institutional Ownership
Cg Oncology Inc
CUSIP 156944100COMCGONQ1 2026
13D / 13G Filings
20
Schedule 13D/13G on record
Beneficial Filers
14
Distinct reporting persons
Largest Stake
11.0%
Max % of class reported
Institutional Holders
227
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
20 filings · latest Nov 12, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Nov 12, 2025 | Wellington Management Group LLP | 13G | 7.2% | 5.51M | SEC |
| 2 | Oct 30, 2025 | The Vanguard Group | 13G/A | 8.6% | 6.58M | SEC |
| 3 | Oct 28, 2025 | Seven Fleet Master Fund LP | 13D/A | 2.0% | — | SEC |
| 4 | Sep 18, 2025 | Longitude Capital Partners IV, LLC | 13D | 6.0% | — | SEC |
| 5 | Sep 18, 2025 | Seven Fleet Partners LP | 13D | 2.0% | — | SEC |
| 6 | Aug 6, 2025 | Fmr LLC | 13G | 5.1% | 3.86M | SEC |
| 7 | May 15, 2025 | Tcg Crossover Gp I, LLC | 13G/A | 11.0% | 3.67M | SEC |
| 8 | Feb 14, 2025 | Decheng Capital Global Life Sciences Fund IV, L.P. | 13G/A | 8.4% | 6.37M | SEC |
| 9 | Jan 28, 2025 | Unique Diamond Investments Limited | 13G/A | 5.5% | 4.21M | SEC |
| 10 | Nov 12, 2024 | Vanguard Group Inc | 13G/A | 7.6% | 5.08M | SEC |
10 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Cg Oncology Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Rtw Investments, LP | 6.98M | $472.73M |
| 2 | Decheng Capital LLC | 6.37M | $431.23M |
| 3 | Wellington Management Group LLP | 5.37M | $363.52M |
| 4 | Blackrock, Inc. | 5.06M | $342.74M |
| 5 | Fmr LLC | 3.76M | $254.80M |
| 6 | Tcg Crossover Management, LLC | 3.67M | $248.40M |
| 7 | State Street Corp | 2.65M | $179.15M |
| 8 | Foresite Capital Management Vi LLC | 2.22M | $150.35M |
| 9 | Geode Capital Management, LLC | 1.60M | $108.10M |
| 10 | Franklin Resources Inc | 1.51M | $101.99M |